• In the past week, Nova Ltd. reported record first‑quarter 2026 results, with revenue of US$235.31 million and GAAP diluted EPS of US$2.04, and issued second‑quarter guidance calling for US$245 million to US$255 million in revenue and US$2.10 to US$2.24 in diluted GAAP EPS.
• Beyond the headline beats, management highlighted record demand across advanced DRAM, advanced packaging, and gate‑all‑around applications, reinforcing Nova’s role in enabling increasingly complex semiconductor manufacturing.
• We’ll now explore how this record quarter and stronger‑than‑expected second‑quarter guidance may reshape Nova’s existing investment narrative.

AI is about to change healthcare. These 28 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Nova Investment Narrative Recap

To own Nova, you need to believe its metrology tools remain essential as chips become more complex across advanced DRAM, gate all around, and advanced packaging. The key short term catalyst is continued order strength from these advanced customers, while the biggest risk is concentration in a handful of large chipmakers whose CapEx can swing quickly. The latest record Q1 results and Q2 guidance support the catalyst but do not remove this concentration risk.

Among recent announcements, Nova’s January 2026 update that leading chipmakers adopted the Metrion platform for gate all around and advanced DRAM stands out. Paired with Q1 2026’s record revenue of US$235.31 million and strong Q2 guidance, this suggests those earlier technology wins are now showing up in reported numbers, which matters directly for the thesis that Nova’s newer platforms can deepen its role at key advanced node and memory customers.

Yet even with these strong updates, investors should still be aware that...

Nova's narrative projects $1.4 billion revenue and $438.7 million earnings by 2029.

Uncover how Nova's forecasts yield a $497.25 fair value, in line with its current price.

Exploring Other Perspectives

Before this record quarter, the most pessimistic analysts were still modeling Nova to reach about US$1.3 billion in revenue and US$413.4 million in earnings by 2029, so you should recognize how differently people can view the same story and consider how these cautious assumptions about advanced node and memory demand might shift after the latest results.

Explore 4 other fair value estimates on Nova - why the stock might be worth less than half the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Nova research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Nova research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Nova's overall financial health at a glance.

Searching For A Fresh Perspective?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Outshine the giants: these 17 early-stage AI stocks could fund your retirement.
• Find 51 companies with promising cash flow potential yet trading below their fair value.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.